Literature DB >> 10336520

Transport of ochratoxin A by renal multispecific organic anion transporter 1.

M Tsuda1, T Sekine, M Takeda, S H Cha, Y Kanai, M Kimura, H Endou.   

Abstract

In the present study, we investigated the transport of ochratoxin A (OTA) by kidney-specific organic anion transporter 1 (OAT1). When expressed in Xenopus laevis oocytes, OAT1 mediated sodium-independent uptake of OTA (Km = 2.1 microM). Piroxicam, which has been shown to prevent the nephrotoxicity of OTA, inhibited OAT1-mediated uptake of OTA. By contrast, another protective compound, aspartame, did not. Using a cell line derived from the mouse kidney terminal proximal tubule (S3) transfected with OAT1 cDNA, we investigated the transport of OTA and also its effect on cell proliferation and cell viability. S3 cells expressing OAT1 mediated the saturable transport of OTA (Km = 0.57 microM). Cell proliferation was suppressed in S3 cells expressing OAT1 when exposed to 2 and 10 microM OTA. This suppression was rescued by the coaddition of 1 mM p-aminohippurate in the media. The present study indicates that OTA is transported by OAT1 and that the accumulation of OTA via OAT1 in proximal tubular cells is the primary event in the development of OTA nephrotoxicity.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10336520

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  15 in total

1.  Uraemic toxins induce proximal tubular injury via organic anion transporter 1-mediated uptake.

Authors:  Masaru Motojima; Atsuko Hosokawa; Hideyuki Yamato; Takamura Muraki; Toshimasa Yoshioka
Journal:  Br J Pharmacol       Date:  2002-01       Impact factor: 8.739

2.  Repair of ochratoxin A-induced DNA damage and modulation of OTA-related genotoxicity by co-incubation with bile acids and methotrexatein vitro.

Authors:  W Föllmann; S Lebrun
Journal:  Mycotoxin Res       Date:  2005-03       Impact factor: 3.833

Review 3.  Renal Drug Transporters and Drug Interactions.

Authors:  Anton Ivanyuk; Françoise Livio; Jérôme Biollaz; Thierry Buclin
Journal:  Clin Pharmacokinet       Date:  2017-08       Impact factor: 6.447

Review 4.  Endocrine and metabolic regulation of renal drug transporters.

Authors:  Lindsay L Yacovino; Lauren M Aleksunes
Journal:  J Biochem Mol Toxicol       Date:  2012-08-29       Impact factor: 3.642

5.  Characterization of hepatobiliary transport systems of a novel alpha4beta1/alpha4beta7 dual antagonist, TR-14035.

Authors:  Minoru Tsuda-Tsukimoto; Tomoji Maeda; Takashi Iwanaga; Toshiyuki Kume; Ikumi Tamai
Journal:  Pharm Res       Date:  2006-09-13       Impact factor: 4.200

Review 6.  Xenobiotic transporters and kidney injury.

Authors:  Blessy George; Dahea You; Melanie S Joy; Lauren M Aleksunes
Journal:  Adv Drug Deliv Rev       Date:  2017-01-20       Impact factor: 15.470

7.  Effects of ochratoxin A on DNA evaluatedin vitro with the single cell gel electrophoresis (Comet assay).

Authors:  S Lebrun; W Föllmann
Journal:  Mycotoxin Res       Date:  2001-06       Impact factor: 3.833

8.  Transport of estrone sulfate by the novel organic anion transporter Oat6 (Slc22a20).

Authors:  Gloriane W Schnabolk; Geri L Youngblood; Douglas H Sweet
Journal:  Am J Physiol Renal Physiol       Date:  2006-02-14

Review 9.  Xenobiotic, bile acid, and cholesterol transporters: function and regulation.

Authors:  Curtis D Klaassen; Lauren M Aleksunes
Journal:  Pharmacol Rev       Date:  2010-01-26       Impact factor: 25.468

10.  Efflux at the Blood-Brain Barrier Reduces the Cerebral Exposure to Ochratoxin A, Ochratoxin α, Citrinin and Dihydrocitrinone.

Authors:  Matthias Behrens; Sabine Hüwel; Hans-Joachim Galla; Hans-Ulrich Humpf
Journal:  Toxins (Basel)       Date:  2021-04-30       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.